International Cancer Imaging Society

International Cancer Imaging Society Meeting and 16th Annual Teaching Course

Cancer Imaging: More Than Meets the Eye

Mon 03 Oct 2016 - Wed 05 Oct 2016

Technology & Innovation Centre (TIC), Glasgow, Scotland, UK

» Meeting details  

» Register here  

Interactive Workshops

Masterclass in Imaging of Prostate Cancer

Mon 24 Oct 2016  Stockholm, Sweden 

» Registration Open 

Masterclass in Imaging of Pancreatic Tumours

Thu 3 Nov 2016  London, UK 

» Registration Open  

Cancer Imaging Journal

Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials.  The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.


» President's Message 

» Latest News 

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 15% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

How I Read Cancer Imaging Studies: The Master Class Series
20 June 2016

How I Read Cancer Imaging Studies: The Master Class Series

New articles in our masterclass series:

68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report by Isabel Rauscher, Tobias Maurer, Wolfgang P. Fendler, Wieland H. Sommer, Markus Schwaiger and Matthias Eiber.

MRI of endometrium cancer – how we do it by Matthias Meissnitzer and Rosemarie Forstner

» Read more

I am so glad I came to ICIS. It was an excellent meeting with very interesting topics and with excellent facilities.  It is always a pleasure to attend ICIS as it is an ideal meeting to interact with people from many countries and to learn about new skills in oncology imaging and novel techniques. You always choose beautiful places for ICIS and we hope to come again next year to London for another wonderful meeting.

MN | Argentina

Register your interest for all ICIS interactive courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on this popular range of courses.

To register your interest, fill in the details below and click on the "Register Interest" button.

Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

TSRI scientists find new cancer drug target in dual-function protein

Published: Mon, 27 Jun 2016 16:00:00 GMT

Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.

Gut bacteria may have role in bile duct cancer

Published: Mon, 27 Jun 2016 14:00:00 GMT

Links between gut bacteria and gastrointestinal cancer are well established. Now, scientists reveal bacteria in the bile duct may also be linked to cancer.

Aggressiveness of acute myeloid leukemia elucidated

Published: Mon, 27 Jun 2016 14:00:00 GMT

Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI) and the University of Basel have discovered why acute leukemias with the same genetic abnormality vary in their...

Adherence to cancer prevention guidelines may reduce risk

Published: Mon, 27 Jun 2016 12:00:00 GMT

Following cancer prevention guidelines on diet and physical activity consistently reduced overall cancer incidence and mortality, as well as reducing risk of breast, endometrial, and colorectal...

Cruciferous vegetables protect against oral cancer, study shows

Published: Mon, 27 Jun 2016 07:00:00 GMT

A new study shows how broccoli sprout extract activates a gene that detoxifies carcinogens, protecting against oral cancer recurrence.

New cancer immunotherapy drugs linked to arthritis in some patients

Published: Mon, 27 Jun 2016 07:00:00 GMT

Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing...

Cancer breakthrough? Novel insight into metastasis could offer new treatments

Published: Fri, 24 Jun 2016 15:00:00 GMT

New cancer treatments could be in the cards, after researchers uncover a new mechanism by which cancer cells spread to other parts of the body and survive.

Healthcare providers do not fully understand cancer risk from CT scans

Published: Fri, 24 Jun 2016 14:00:00 GMT

Knowledge of radiation dose and associated risks varies among referring physicians, radiologists, and technicians, according to a new study in the Journal of Medical Imaging and Radiation Sciences.

Mycobacterium in olive oil for cancer treatment

Published: Thu, 23 Jun 2016 14:00:00 GMT

Researchers at the Universitat Autònoma de Barcelona (UAB) with the collaboration of the Institute for Bioengineering of Catalonia (IBEC), led by the professor of the UAB Department of Genetics...

Tumor cells develop predictable characteristics that are not random, say Moffitt Cancer Center researchers

Published: Wed, 22 Jun 2016 07:00:00 GMT

Moffitt researchers use mathematical model to show that cells in the exterior and interior of a tumor develop different predictable characteristics.

CAR T cell therapy can now target solid tumors: Mouse study

Published: Tue, 21 Jun 2016 16:00:00 GMT

Chimeric antigen receptor (CAR) T cell therapy, which edits a cancer patient's T cells to recognize their tumors, has successfully helped patients with aggressive blood cancers but has yet to show...

Study finds surgery can lengthen survival of metastatic kidney cancer patients

Published: Tue, 21 Jun 2016 16:00:00 GMT

Surgery to remove a cancerous kidney can often lengthen the lives of patients receiving targeted therapy for metastatic kidney cancer, but only about three in ten such patients undergo the...

High blood sugar could mean lower risk of one type of brain tumor

Published: Tue, 21 Jun 2016 14:00:00 GMT

Study finds women with high blood sugar have lower risk of benign tumors.In a surprising twist, benign brain tumors that have previously been tied to obesity and diabetes are less likely to...

Low doses of common cancer drug may promote cancer spread

Published: Tue, 21 Jun 2016 14:00:00 GMT

New research indicates that paclitaxel, which is the most commonly used chemotherapy for breast cancer, suppresses tumors when given at a certain dosage, but at low doses, it actually promotes...

Illuminating detection of deep cancers

Published: Tue, 21 Jun 2016 14:00:00 GMT

A luciferin analog generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging.

Brain tumor risk linked to high education level

Published: Tue, 21 Jun 2016 07:00:00 GMT

A new population-wide study shows gliomas are more common among people who studied at university for 3 years, compared with those who did not.

Breast cancer: Existing drug shows promise for prevention in high-risk women

Published: Tue, 21 Jun 2016 07:00:00 GMT

An existing drug called denosumab has shown promise for the delay or prevention of breast cancer among women with a BRCA1 mutation.

microRNAs help to predict disease progression in brain tumors

Published: Mon, 20 Jun 2016 16:00:00 GMT

Scientists at the Helmholtz Zentrum München and the Ludwig Maximilians University of Munich (LMU) have developed a new method of predicting disease progression in gliobastoma patients who have...

Breast cancer cells use newfound pathway to survive low oxygen levels in tumors

Published: Mon, 20 Jun 2016 16:00:00 GMT

Researchers have identified a new signaling pathway that helps cancer cells cope with the lack of oxygen found inside tumors.

New mechanism activates the immune system against tumor cells

Published: Mon, 20 Jun 2016 11:00:00 GMT

The body's defences detect and eliminate not only pathogens but also tumour cells.